Inactivation of viral infections agents by chemiluminescence activated light-sensitive compounds |
| The present invention relates to chemiluminescence-directed antiviral activities of natural and ... |
|
Isoflavone compositions produced from legumes |
| In the broadest aspect of this invention there is provided processes for the production of ... |
|
Methods for inducing HIV-neutralizing antibodies |
| The invention claimed is: 1. A method for inducing antibodies neutralizing HIV primary isolates in ... |
|
Process for manufacturing a high protein food material |
| It is one of the objects of this invention to provide a food formulation that has a high-protein ... |
|
Microwave sludge drying apparatus and method |
| The Microwave Sludge Drying Apparatus of the present invention is generally comprised of an ... |
|
Microwave-assisted extraction from materials containing organic matter |
| OF THE PREFERRED APPARATUS EMBODIMENTS Referring now to FIG. 1, shown is the apparatus of the ... |
|
Food container |
| The invention claimed is: 1. A method for heating food in a container, the container comprising a ... |
|
Solid lipid compositions of lipophilic compounds for enhanced oral bioavailability |
| This invention is directed to dry solid lipid compositions useful for the oral delivery of ... |
|
|
Method for chemoprevention of prostate cancer
| Details |
Inventors: Steiner, Mitchell S.; Raghow, Sharan;
Assignee: The University of Tennessee Research Corporation (Knoxville, TN)
Primary Examiner: Page; Thurman K.
Assistant Examiner: Fubara; Blessing
Attorney, Agent or Firm: Eitan, Pearl, Latzer & Cohen-Zedek, Cohen; Mark S.
This invention provides the chemoprevention of prostate cancer and, more particularly, to a method of preventing prostate carcinogenesis comprising the steps of administering to a human subject having a precancerous precursor of prostate adenocarcinoma, a pharmaceutical preparation comprising a chemopreventive agent to prevent, prevent recurrence of, suppress or inhibit prostate carcinogenesis. The present invention provides a safe and effective method for suppressing or inhibiting latent prostate cancer and is particularly useful for treating subjects having elevated risk of developing prostate cancer, for example, those having benign prostatic hyperplasia, prostate intraepithelial neoplasia (PIN), or an abnormally high level of circulating prostate specific antibody (PSA), or who have a family history of prostate cancer. |
|
DETAILED DESCRIPTION This invention provides the chemoprevention of prostate cancer and, more particularly, to a method of administering to a subject an effective dose of an antiestrogen to prevent, prevent recurrence of, and/or suppress or inhibit prostate carcinogenesis. This invention provides the chemoprevention of prostate cancer and, more particularly, to a method of administering to a subject an effective dose of an antiestrogen which does not cause the formation of DNA adducts, to prevent, prevent recurrence of, and/or suppress or inhibit prostate carcinogenesis. This invention provides the chemoprevention of prostate cancer and, more particularly, to a method of administering to a subject an effective dose of a chemopreventive agent, toremifene and analogs or metabolites thereof, to prevent, prevent recurrence of, and/or suppress or inhibit prostate carcinogenesis. The present invention is directed to a method for preventing prostate carcinogenesis with an antiestrogen which does not cause the formation of DNA adducts. Further, this invention involes administering to a mammalian subject a pharmaceutical preparation of a chemopreventive agent having the formula: ##STR1## wherein R. sub. 1 and R. sub. 2, which can be the same or different, are H or OH, R. sub. 3 is OCH. sub. 2 CH. sub. 2 NR. sub. 4 R. sub. 5, wherein R. sub. 4 and R. sub. 5, which can be the same or different, are H or an alkyl group of 1 to about 4 carbon atoms; and their pharmaceutically acceptable carrier, diluents, salts, esters, or N-oxides, and mixtures thereof. The present invention provides a safe and effective method for suppressing or inhibiting latent prostate cancer and is particularly useful for treating subjects having an elevated risk of developing prostate cancer, for example, those having benign prostatic hyperplasia, prostate intraepithelial neoplasia (PIN), or an abnormally high level of circulating prostate specific antibody (PSA), or who have a family history of prostate cancer.
|
| Related patents |
|
|
Method for chemoprevention of prostate cancer
This invention relates to the chemoprevention of prostate cancer and, more particularly, to a method of suppressing or inhibiting latent prostate cancer comprising the ...
|
|
|
Food additive composition
OF THE PREFERRED EMBODIMENTS The present invention is directed to food supplement compositions containing a wide variety of beans, grains, vitamins, herbs, and spices ...
|
|
|
Method for chemoprevention of prostate cancer
This invention related to a method for preventing prostate carcinogenesis of a subject comprising: administering to a mammalian subject, a pharmaceutical preparation ...
|
|
|
Placental alkaline phosphatase to control diabetes
In one embodiment, the present invention provides a method of reducing plasma glucose level in a mammal, comprising the step of administering a therapeutically effective ...
|
|
|
Process for producing malt alcoholic drink
The invention claimed is: 1. A method of producing a malt alcohol beverage, comprising: removing through adsorption at least a part of rough flavor components from malt, ...
|
|
|
Delivery of controlled-release system (s)
OF THE INVENTION The present invention is a method of making comestible units which disintegrate quickly in the mouth of the consumer. The units produced in accordance ...
|
|
|
Composition for the treatment of cutaneous mycosis
I claim: 1. An antifungal powder composition for the treatment of cutaneous mycosis that consists essentially of 70 to 99 weight percent natural quartz and at least one ...
|
|
|
Sustained release compositions for treating periodontal disease
OF THE INVENTION The essential as well as optional components of the compositions of this invention are described below. Monoolein The gelling agent useful with the ...
|
|
|
Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic
OF THE INVENTION The present invention relates to the pharmaceutical dental gel formulation for topical application in the form of aqueous gel suitable for the ...
|
|
|
Prevention of crystal formation in toothpaste
OF THE INVENTION The dentifrices of the present invention include toothpastes, dental creams, or dental gels. They comprise the several essential, as well as optional, ...
|
|
|